Health Tech Capitol | Cellectar, Pierre Fabre Extend Relationship
16062
post-template-default,single,single-post,postid-16062,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Cellectar, Pierre Fabre Extend Relationship

10 Oct Cellectar, Pierre Fabre Extend Relationship

Posted at 16:19h in Uncategorized by
0 Likes

Cellectar Biosciences has extended its collaboration with Pierre Fabre, a French pharmaceutical company, the company announced today.

“The extension of our research agreement with Pierre Fabre allows us to further progress the development of an exciting new class of novel targeted antitumor agents and underscores the promise of our next generation delivery technology,” Cellectar Biosciences CEO Jim Caruso said in a statement.

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.